The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA Nephropathy

The goal of this clinical trial is to learn if Shenqi Yishen Granules works to treat IgA Nephropathy in adults. It will also learn about the safety of Shenqi Yishen Granules. The main questions it aims to answer are: Does Shenqi Yishen Granules lower 24-hour urinary protein quantification of participants? What medical problems do participants have when taking Shenqi Yishen Granules? Researchers will compare Shenqi Yishen Granules to a placebo (a look-alike substance that contains no drug) to see if Shenqi Yishen Granules works to treat IgA Nephropathy.

NCT Number	NCT07360002
Lead Sponsor	Keda Lu Collaborators: The First Affiliated Hospital of Zhejiang Chinese Medical University, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Red Cross Hospital, Hangzhou, China, Hangzhou Hospital of Traditional Chinese Medicine, Zhenhai District Traditional Chinese Medicine Hospital, Jiangsu Province Hospital of Traditional Chinese Medicine, Shao Yifu Hospital of Zhejiang Medical University, First Affiliated Hospital of Zhejiang University, Yuyao City Traditional Chinese Medicine Hospital, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Affiliated Hospital of Jiaxing University, Hangzhou Xiaoshan First People's Hospital, Shanghai 6th People's Hospital
Conditions	IgA Nephropathy (IgAN)
Enrollment	102 participants
Start Date	2026-01
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-01-22